GCGR and Hypoglycemia: Neither approach to disruption of GCGR function results in overt hypoglycemia; this suggests that pharmacotherapy aimed at antagonizing glucagon action at the GCGR may provide useful reductions in blood glucose without significantly increasing risk for hypoglycemia.